Airscream Plans to Invest 100 Million Ringgit in Malaysia

Business by 2FIRSTS.ai
Apr.07.2024
Airscream Plans to Invest 100 Million Ringgit in Malaysia
Airscream, a UK e-cigarette company, to invest 100 million Malaysian Ringgit in Malaysia over the next five years.

According to a recent report from MSN, the UK-based e-cigarette company Airscream is planning to invest 100 million Malaysian Ringgit (21.07 million USD) in Malaysia over the next five years. The e-cigarette market in Malaysia is booming, with a market value of over 3 billion Malaysian Ringgit (630 million USD) and a workforce of over 30,000 employees. The company sees Malaysia as a key region for its global business.

 

The company's CEO, Sam Ong, stated that the maturation of Malaysia's e-cigarette market is bringing in more investments and better job opportunities. He is excited about Malaysia's newly introduced Public Health Tobacco Control Act, which regulates e-cigarettes and smoking devices, introducing new rules such as mandatory registration of all smoking products, prohibiting the sale and promotion of smokeless products, addressing previously unregulated health emergencies, and more. He mentioned that this legislation aligns Malaysia with international standards set by countries like the UK, Australia, Thailand, and Singapore.

 

Currently, the company has established a team in Shanghai with 40 local employees and 100 global employees. They aim to closely collaborate with local officials, industry regulators, manufacturers, distributors, and interest groups to jointly improve the e-cigarette industry.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.